Health Condition 1: L659- Nonscarring hair loss, unspecified
Conditions
Interventions
None listed
Sponsors
Emami Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1.Male subjects aged between 20 to 55 years and female subjects aged between 18 to 45 years. 2.Individuals experiencing hair fall, hair thinning, or complaints of poor hair texture for at least 3 months. 3.Subjects who are willing to sign informed consent for participation in the study and willing to adhere to all protocol procedures
Exclusion criteria
Exclusion criteria: 1.Participants with a known allergy or hypersensitivity to any ingredient in the Zandu Hair Growth Ayurvedic Capsule or similar products. 2.Individuals with significant dermatological conditions affecting the scalp, such as psoriasis, eczema, seborrheic dermatitis, or active scalp infections. 3.Participants who have undergone hair treatments such as hair transplants, chemical treatments (dyes, perms, straightening), or the use of hair growth products (e.g., minoxidil, finasteride) within the last 6 months. 4.Pregnant or breastfeeding women. 5.Participants currently taking or having taken hormonal therapies (e.g., corticosteroids, hormonal birth control, testosterone supplements) within the past 3 months. 6.Participants who have undergone major surgery within the last 3 months. 7.Individuals who have received chemotherapy or radiation therapy within the past 12 months. 8.Current significant cardiovascular, respiratory, gastrointestinal, hepatic, renal, neurological, psychiatric and/or hematological disease as evaluated by the Investigator. 9.Concurrent participation in another clinical trial or any investigational therapy within 30 days prior to signing informed consent. 10.Currently taking prohibited concomitant medications(s) listed and inability/unwillingness to discontinue them for the entire study period. 11.Suspected inability or unwillingness to comply with the study procedures. 12.Female subjects of childbearing potential not be willing to use an acceptable method of contraception. 13.Pregnant woman or lactating mother.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increase in Hair Growth: Measured by hair count and hair length from standardized scalp areas, before and after 90 days of treatmentTimepoint: 90 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in Hair Fall: Assessed through participant-reported hair shedding (e.g., hair strands lost during combing or washing), and visual or quantitative assessments at baseline and after 90 days. 2. Improvement in Hair Texture: Evaluated by participant feedback on parameters such as smoothness, shine, strength, and general hair health, measured on a Likert scale or visual analog scale (VAS). 3. Increase in Hair Density: Assessed by dermatological examination or trichoscopy to measure the thickness and volume of hair in predefined scalp areas, comparing baseline and end-of-study results. Timepoint: 90 days | — |
Countries
India
Contacts
Public ContactSandeep Yadav
Manentia Research Private Limited
Outcome results
None listed